Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells

• DOI: 10.1016/j.molimm.2009.06.017
• Publication Date: 2009-07-18T05:09:14Z
• Authors: Michael Reich; Adam Lesner; Anna Łęgowska; Marcin Sieńczyk; Jozef Oleksyszyn; Bernhard O. Boehm; Timo Burster
• Keywords: Antigen processing; Cathepsin G

The serine protease cathepsin G (CatG) is expressed in primary antigen-presenting cells and regulates autoantigen processing in CatG pre-loaded fibroblasts. To further investigate the function of CatG in the major histocompatibility complex (MHC) class II loading compartments, a specific, cell permeable CatG-inhibitor is needed. In this study, several CatG-inhibitors were tested for their ability to penetrate the cell membrane of peripheral blood mononuclear cells (PBMC). We find that the commercially available reversible CatG-specific inhibitor I (CatG inhibitor) and the irreversible Suc-Val-Pro-Phe(P) (OPh)(2) (Suc-VPF) are both cell permeable and specifically inhibit intracellular CatG in the PBMC. Furthermore, selective inhibition of CatG resulted in reduced tetanus toxin C-fragment (TTC) and hemagglutinin (HA) processing and presentation to CD4(+) T cells. We conclude that these CatG inhibitors can be used for both antigen-processing studies and for modulation of T cell response in situ and in vivo.